Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Harlé

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Pathology Oncology Research : POR|November 15, 2018
Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast CarcinomasA Lambert, J Salleron, M Lion, et al.
BMC Cancer|March 30, 2019
HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case reportAlexandre Harlé, Julie Guillet, Jacques Thomas, et al.
Oncology Letters|December 1, 2016
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targetsShuhui Chen, Elisa Cavazza, Catherine Barlier, et al.
Cancers|October 27, 2022
Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 TrialJulie Egea, Julia Salleron, Sophie Gourgou, et al.
Targeted Oncology|December 15, 2015
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation SequencingAlexandre Harlé, Pierre Filhine-Tresarrieu, Marie Husson, et al.
Plos One|February 28, 2019
Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinomaClaire Franczak, Ludovic Dubouis, Pauline Gilson, et al.
Translational Oncology|February 5, 2025
Decoding mutational signatures in breast cancer: Insights from a multi-cohort studyMargaux Betz, Andréa Witz, Julie Dardare, et al.
Scientific Reports|November 1, 2023
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell linesAndréa Witz, Julie Dardare, Aurélie Francois, et al.
Scientific Reports|May 10, 2019
Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencingClaire Franczak, Shaun M Kandathil, Pauline Gilson, et al.
Plos One|July 3, 2019
Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisationPauline Gilson, Claire Franczak, Ludovic Dubouis, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Pathology Oncology Research : POR|November 15, 2018
Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast CarcinomasA Lambert, J Salleron, M Lion, et al.
BMC Cancer|March 30, 2019
HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case reportAlexandre Harlé, Julie Guillet, Jacques Thomas, et al.
Oncology Letters|December 1, 2016
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targetsShuhui Chen, Elisa Cavazza, Catherine Barlier, et al.
Cancers|October 27, 2022
Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 TrialJulie Egea, Julia Salleron, Sophie Gourgou, et al.
Targeted Oncology|December 15, 2015
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation SequencingAlexandre Harlé, Pierre Filhine-Tresarrieu, Marie Husson, et al.
Plos One|February 28, 2019
Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinomaClaire Franczak, Ludovic Dubouis, Pauline Gilson, et al.
Translational Oncology|February 5, 2025
Decoding mutational signatures in breast cancer: Insights from a multi-cohort studyMargaux Betz, Andréa Witz, Julie Dardare, et al.
Scientific Reports|November 1, 2023
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell linesAndréa Witz, Julie Dardare, Aurélie Francois, et al.
Scientific Reports|May 10, 2019
Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencingClaire Franczak, Shaun M Kandathil, Pauline Gilson, et al.
Plos One|July 3, 2019
Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisationPauline Gilson, Claire Franczak, Ludovic Dubouis, et al.
Pageof 7